Insiders Updates
Canaccord Genuity initates Aeva Technologies Inc (AEVA) rating to a Buy
Aeva Technologies Inc’s recent filing unveils that its Chief Financial Officer Sinha Saurabh unloaded Company’s shares for reported $0.48 million ...
Analyzing Mueller Water Products Inc (MWA) After Recent Trading Activity
Mueller Water Products Inc’s recent filing unveils that its Former EVP, CFO, CLO and CCO Heinrichs Steven S unloaded Company’s ...
Vir Biotechnology Inc [VIR] Investment Appeal on the Rise
Vir Biotechnology Inc’s recent filing unveils that its 10% Owner SVF Endurance (Cayman) Ltd unloaded Company’s shares for reported $1.15 ...
The Potential Rise in the Price of Teads Holding Co (TEAD) following insiders activity
Teads Holding Co’s recent filing unveils that its Director Krindel Yaffa acquired Company’s shares for reported $6000.0 on Dec 11 ...
Investing in Radian Group, Inc (RDN) Is Getting More Attractive
Radian Group, Inc’s recent filing unveils that its Sr EVP, Chief Digital Officer Ray Eric unloaded Company’s shares for reported ...
Taking a Closer Look At Huntington Ingalls Industries Inc (HII) Following Its Recent Trade
Huntington Ingalls Industries Inc’s recent filing unveils that its Ex VP & Chief Legal Officer Boudreaux Chad N. unloaded Company’s ...
Latest Insider moments: Quigley Jill M., Terns Pharmaceuticals Inc [TERN] Director sold 24,520 shares
Terns Pharmaceuticals Inc’s recent filing unveils that its Director Quigley Jill M. unloaded Company’s shares for reported $0.44 million on ...
A company insider recently sold 947 shares of Entergy Corp [ETR]. Should You also Consider to Sale?
Entergy Corp’s recent filing unveils that its “Officer” Under Sec. 16 Rules VIAMONTES ELIECER unloaded Company’s shares for reported $92011.0 ...
KKR & Co. Inc’s latest rating changes from various analysts
KKR & Co. Inc’s recent filing unveils that its 10% Owner KKR Group Partnership L.P. unloaded Company’s shares for reported ...
Wolfe Research Upgrades Alnylam Pharmaceuticals Inc (ALNY) to a Peer perform from an Underperform
Alnylam Pharmaceuticals Inc’s recent filing unveils that its CSO & EVP, Head of Research Fitzgerald Kevin Joseph unloaded Company’s shares ...
